Skip to content

The clinical application of one stage shaped skin graft in situ in inter-sphincter anal fistula:a randomized controlled trial

The clinical application of one stage shaped skin graft in situ in inter-sphincter anal fistula:a randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900021457
Enrollment
Unknown
Registered
2019-02-22
Start date
2019-03-01
Completion date
Unknown
Last updated
2019-02-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anal fistula

Interventions

Experimental group:fistulectomy(or with cut setton) with one stage shaped skin graft in situ
Control group:fistulectomy(or with cut setton)

Sponsors

The First Affiliated Hospital of Guangzhou University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Anal fistula patients meet the diagnostic criteria listed in the study protocol files; 2. Aged from 18-60 years; 3. Normal anal morphology and function; 4. understanding,agreeing to join the study and completing the follow-up.

Exclusion criteria

Exclusion criteria: 1. Patients with traumaIBDmalignant tumourHIVtuberculosisactinomycotic infection; 2. Special patientspregnant and lactating womenwith respiratorydigestivecirculationblood system disordersliver and kidney defunction; 3. Abnormal blood sugar leveland/or other special factors (radiation damageburn) that affect the wound healing; 4. Acute infected anal fistula; 5. Patients with abnormal anal morphology and function; 6. Non-first time operation; 7. Disagree to join the trial or complete the follow-up.

Design outcomes

Primary

MeasureTime frame
Hospital-stay;Duration of operation;Wound-healing;Follow-up;Wound condition for healing;Recurrence;Back to work;The costs;vital signs;Wound pain;Wound bleeding;Urine retention;Anal function by Wexner Scale;Complications;postoprative wound infection;

Contacts

Public ContactYuying Li

The First Affiliated Hospital of Guangzhou University of Chinese Medicine

lyy3855@163.com+86 13711431166

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026